1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Aspergillosis Invasive: new trials by email Literature Review of Aspergillosis Invasive trials Research Report on Aspergillosis Invasive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis Isavuconazonium Injection [Cresemba], Placebo - Severe Acute Respiratory Syndrome Coronavirus 2, Aspergillosis Invasive | Phase 3 | Terminated | Jeffrey Jenks, MD, MPH | 8 | 2021-03-16 | 2022-11-25 |
isavuconazole (1)
United States (1)
George Thompson, MD (1) · Jeffrey Jenks, MD, MPH (1) · Martin Hoenigl, MD (1)